Access Bio Inc (950130) — Cash Flow Quality Index
Latest as of June 2024:
-6.44x
Access Bio Inc (950130) has a Cash Flow Quality Index of -6.44x as of June 2024. Operating cash flow of ₩-9.83 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Access Bio Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-6.44x
Operating CF / Net Income
Operating Cash Flow
₩-9.83 Billion
KRW
Net Income
₩1.53 Billion
KRW
Data as of
Jun 2024
Most recent filing
Access Bio Inc Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for Access Bio Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 950130 operating cash flow.
Annual Cash Flow Quality Index for Access Bio Inc (2012–2022)
Year-by-year earnings quality comparison for Access Bio Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | ₩291.33 Million | ₩346.67 Billion | ▲ +15.6% |
| 2021 | 0.00x | ₩137.90 Million | ₩189.69 Billion | ▼ -99.9% |
| 2020 | 0.76x | ₩36.72 Billion | ₩48.27 Billion | ▼ -66.4% |
| 2015 | 2.26x | ₩2.87 Billion | ₩1.27 Billion | ▲ +309.1% |
| 2014 | -1.08x | ₩-2.63 Billion | ₩2.43 Billion | ▼ -634.9% |
| 2013 | 0.20x | ₩1.59 Billion | ₩7.84 Billion | ▼ -18.3% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.45 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.